- Home
- VECO vs CNTA Comparison
VECO vs CNTA Comparison
Compare VECO & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VECO
- CNTA
- Stock Information
- Founded
- VECO 1945
- CNTA 2020
- Country
- VECO United States
- CNTA United Kingdom
- Employees
- VECO N/A
- CNTA N/A
- Industry
- VECO Industrial Machinery/Components
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- VECO Technology
- CNTA Health Care
- Exchange
- VECO Nasdaq
- CNTA Nasdaq
- Market Cap
- VECO 1.4B
- CNTA 2.3B
- IPO Year
- VECO 1994
- CNTA 2021
- Fundamental
- Price
- VECO $26.78
- CNTA $21.33
- Analyst Decision
- VECO Buy
- CNTA Strong Buy
- Analyst Count
- VECO 6
- CNTA 11
- Target Price
- VECO $27.33
- CNTA $30.60
- AVG Volume (30 Days)
- VECO 919.1K
- CNTA 1.4M
- Earning Date
- VECO 11-05-2025
- CNTA 11-11-2025
- Dividend Yield
- VECO N/A
- CNTA N/A
- EPS Growth
- VECO N/A
- CNTA N/A
- EPS
- VECO 1.02
- CNTA N/A
- Revenue
- VECO $700,334,000.00
- CNTA $15,000,000.00
- Revenue This Year
- VECO N/A
- CNTA N/A
- Revenue Next Year
- VECO $8.48
- CNTA N/A
- P/E Ratio
- VECO $26.18
- CNTA N/A
- Revenue Growth
- VECO N/A
- CNTA 118.88
- 52 Week Low
- VECO $16.92
- CNTA $9.60
- 52 Week High
- VECO $34.34
- CNTA $23.24
- Technical
- Relative Strength Index (RSI)
- VECO 69.45
- CNTA 66.36
- Support Level
- VECO $24.52
- CNTA $21.47
- Resistance Level
- VECO $25.96
- CNTA $23.24
- Average True Range (ATR)
- VECO 0.76
- CNTA 1.27
- MACD
- VECO 0.12
- CNTA 0.47
- Stochastic Oscillator
- VECO 98.02
- CNTA 76.79
About VECO Veeco Instruments Inc.
Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.